Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial - PubMed (original) (raw)
Clinical Trial
. 2003 Jul;14(7 Suppl 2):S108-13.
doi: 10.1097/01.asn.0000070157.96264.13.
Johan G Eriksson, Timo T Valle, Sirkka Aunola, Zygimantas Cepaitis, Martti Hakumäki, Helena Hämäläinen, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso, Anne Louheranta, Marjo Mannelin, Vesa Martikkala, Vladislav Moltchanov, Merja Rastas, Virpi Salminen, Jouko Sundvall, Matti Uusitupa, Jaakko Tuomilehto
Affiliations
- PMID: 12819313
- DOI: 10.1097/01.asn.0000070157.96264.13
Clinical Trial
Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial
Jaana Lindström et al. J Am Soc Nephrol. 2003 Jul.
Abstract
Type 2 diabetes mellitus is increasing worldwide largely as a result from increasing obesity and sedentary lifestyle. The Finnish Diabetes Prevention Study (DPS) is the first individually randomized controlled clinical trial to test the feasibility and efficacy of lifestyle modification in high-risk subjects. We randomly assigned 522 (172 men, 350 women) middle-aged (mean age 55 yr), overweight (mean body mass index 31 kg/m(2)) subjects with impaired glucose tolerance either to the lifestyle intervention or control group. Each subject in the intervention group received individualized counseling aimed at reducing weight and intake of total and saturated fat, and increasing intake of fiber and physical activity. An oral glucose tolerance test was performed annually to detect incident cases of diabetes and to measure changes in metabolic parameters. The mean (+/- SD) weight reduction from baseline to year 1 and to year 2, respectively, was 4.2 +/- 5.1 kg and 3.5 +/- 5.5 in the intervention group and 0.8 +/- 3.7 kg and 0.8 +/- 4.4 in the control group (P < 0.001 between the groups). At the time of first analysis of the outcome data the mean duration of follow-up was 3.2 yr. The risk of diabetes was reduced by 58% (P < 0.001) in the intervention group compared with the control group. The reduction in the incidence of diabetes was directly associated with number and magnitude of lifestyle changes made. In conclusion, the DPS is the first controlled trial demonstrating that type 2 diabetes can be prevented by changes in lifestyle in high-risk subjects.
Similar articles
- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Tuomilehto J, et al. N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801. N Engl J Med. 2001. PMID: 11333990 Clinical Trial. - How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study.
Ruusunen A, Voutilainen S, Karhunen L, Lehto SM, Tolmunen T, Keinänen-Kiukaanniemi S, Eriksson J, Tuomilehto J, Uusitupa M, Lindström J. Ruusunen A, et al. Diabet Med. 2012 Jul;29(7):e126-32. doi: 10.1111/j.1464-5491.2012.03602.x. Diabet Med. 2012. PMID: 22313027 Clinical Trial. - The Finnish Diabetes Prevention Study.
Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, Tuomilehto J. Uusitupa M, et al. Br J Nutr. 2000 Mar;83 Suppl 1:S137-42. doi: 10.1017/s0007114500001070. Br J Nutr. 2000. PMID: 10889804 Clinical Trial. - Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis.
Uusitupa M, Khan TA, Viguiliouk E, Kahleova H, Rivellese AA, Hermansen K, Pfeiffer A, Thanopoulou A, Salas-Salvadó J, Schwab U, Sievenpiper JL. Uusitupa M, et al. Nutrients. 2019 Nov 1;11(11):2611. doi: 10.3390/nu11112611. Nutrients. 2019. PMID: 31683759 Free PMC article.
Cited by
- Effects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China.
Chi XX, Zhang T, Zhang DJ, Yu W, Wang QY, Zhen JL. Chi XX, et al. J Clin Biochem Nutr. 2016 Sep;59(2):134-138. doi: 10.3164/jcbn.15-147. Epub 2016 Jun 10. J Clin Biochem Nutr. 2016. PMID: 27698541 Free PMC article. - Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.
Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Balk EM, et al. Ann Intern Med. 2015 Sep 15;163(6):437-51. doi: 10.7326/M15-0452. Ann Intern Med. 2015. PMID: 26167912 Free PMC article. Review. - Primary Prevention of Type 2 Diabetes Mellitus in the European Union: A Systematic Review of Interventional Studies.
Andrade CAS, Lovas S, Mahrouseh N, Chamouni G, Shahin B, Mustafa EOA, Muhlis ANA, Njuguna DW, Israel FEA, Gammoh N, Chandrika N, Atuhaire NC, Ashkar I, Chatterjee A, Charles R, Alzuhaily H, Almusfy A, Díaz Benavides D, Alshakhshir FK, Varga O. Andrade CAS, et al. Nutrients. 2025 Mar 17;17(6):1053. doi: 10.3390/nu17061053. Nutrients. 2025. PMID: 40292470 Free PMC article. Review. - Diabetes in sports.
Shugart C, Jackson J, Fields KB. Shugart C, et al. Sports Health. 2010 Jan;2(1):29-38. doi: 10.1177/1941738109347974. Sports Health. 2010. PMID: 23015921 Free PMC article. - Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.
Watson K. Watson K. Curr Cardiol Rep. 2006 Nov;8(6):433-8. doi: 10.1007/s11886-006-0101-3. Curr Cardiol Rep. 2006. PMID: 17059795 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical